Screening to learn your risk for genetic COPD has never been easier.
Alpha-1 Antitrypsin Deficiency (AATD), also called alpha-1 or genetic COPD, is an inherited condition that runs in families and primarily affects the lungs and liver. Alpha-1 symptoms are the same as traditional COPD symptoms, and as a result alpha-1 can go undetected for years. It is important to learn your risk for alpha-1 and screening is the first step.
AlphaID™ At Home is the only free*, easy, FDA-cleared genetic health risk service that detects 14 variants in the SERPINA1 gene linked to AATD with at least 99% accuracy. The service also determines your risk for developing lung and/or liver disease linked to alpha-1 compared with the general population. AlphaID™ At Home empowers you to find out your risk, especially if your provider can’t test you or you aren’t able to get to your provider easily. Leading health organizations recommend all COPD patients get tested for alpha-1.
*The Genetic Health Risk Service, including the kit, is provided for free and may not be billed to patients or their insurers. There is no obligation to purchase or use any product or service offered by any manufacturer
Grifols, a global healthcare company, offers AlphaID™ At Home to determine the risk of developing lung and/or liver disease linked to AATD compared to the general population.
